Kardigan Inc
KARDHealthcare|Biotechnology|USA
$24.55
+0.18 (+0.76%)
Clinical Trials (4)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07001800 Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study | Moderate Aortic Valve Stenosis | P2P3 | Recruiting | 1,276 | RCT, Double-blind | Ataciguat, Placebo |
| NCT07210723 A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy | Symptomatic Genetic Dilated Cardiomyopathy | P2P3 | Recruiting | 332 | RCT, Double-blind | danicamtiv, Placebo |
| NCT07511361 Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension | Hypertension, Acute Severe Hypertension | P2 | Recruiting | 140 | RCT, Double-blind | Tonlamarsen, Placebo |
| NCT06864104 A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL) | Hypertension | P2 | Completed | 206 | RCT, Double-blind | Tonlamarsen, Placebo |